STAR Campus lives up to its name with Chemours, pharma announcements


Good morning all,

News that Chemours will build a research and development center on the University of Delaware’s STAR Campus in Newark brought a ho-hum reaction in some quarters.

After all, it was common knowledge in some circles that the Chemours deal was in the works. Also, the $150 million project would move 300 jobs down I-95, with no guarantees of additional employment.

Still, the significance of the project goes well beyond the headcount.

Chemours will have more of an opportunity to work with the world-class researchers at UD. In fact, the opportunity for partnering with the university was cited as one of the reasons for the move to Newark.


The announcement also comes after a successful effort to land a private-public partnership that will lead to  the headquarters for a national research and development center for pharmaceutical manufacturing.

UD went far beyond the minimum requirements for the center and will construct a larger structure with room for researchers and start-ups that could provide a further boost to the STAR campus and the state economy.

The twin announcements also tell us why the STAR  Campus was not put in the mix for Delaware’s long-shot effort for Amazon’s HQ2 project.

In some ways, the STAR Campus checked off many of Amazon’s boxes. A college town in a metro area fits Amazon’s vision. The train station is another drawing card.

Still,  STAR seems to have a winning formula in place and dropping everything to pursue Amazon would not have made sense.

As always, your thoughts and observations are welcome. If this newsletter was forwarded to you,  click here   to subscribe at no charge. – Doug Rainey, Publisher